Torq, the established Agentic AI security operations pioneer, today announced it has closed a massive $140 million Series D ...
Is Trevi Therapeutics (TRVI) Building a Multi-Indication Moat With Its Nalbuphine ER Cough Strategy?
Trevi Therapeutics recently outlined past and upcoming milestones for its chronic cough portfolio, including an FDA End-of-Phase 2 meeting in early 2026 and planned Phase 3 and Phase 2b trial ...
Detailed price information for Zentalis Pharmaceuticals Inc (ZNTL-Q) from The Globe and Mail including charting and trades.
REGENXBIO Inc. highlighted progress and upcoming anticipated milestones across its pipeline of AAV gene therapies for rare and retinal diseases. "2026 is set to be a transformative year for REGENXBIO, ...
What a great day we had at the Tractor, Truck & Vintage Car Run last weekend! The turnout was fantastic, the vehicles were ...
Prime non-landed and landed residential markets posted year-on-year growth in 2025, Knight Frank Singapore found.
Singapore car buyers are shifting purchase plans towards internal combustion engine vehicles, with 32% indicating an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results